PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | |hepatocellular carcinoma |
| Sentences | 82 |
| PubMedID- 26182318 | Development of hepatocellular carcinoma (hcc) in patients with autoimmune liver disease is less common than in those with other types of chronic liver disease. |
| PubMedID- 24632765 | Statin therapy seems to be related to a reduced risk for hepatocellular carcinoma in patients with chronic liver disease, but randomized data are lacking. |
| PubMedID- 20148264 | Purpose: the optimum strategy, hepatic resection (hr) or liver transplantation (lt), for treatment of early hepatocellular carcinoma (hcc) associated with liver diseases of child-pugh a is far from established. |
| PubMedID- 26274335 | Association of nonalcoholic fatty liver disease (nafld) with hepatocellular carcinoma (hcc) in the united states from 2004 to 2009. |
| PubMedID- 20619382 | Background: hepatitis c virus (hcv) causes chronic liver disease that often leads to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 22848841 | The hepatitis c virus (hcv) is one of the most prevalent causes of chronic liver disease worldwide and leads to cirrhosis and hepatocellular carcinoma in a high percentage of carriers [1, 2].insulin resistance (ir), impaired glucose tolerance, and type 2 diabetes mellitus (dm) are frequent extrahepatic manifestations [3, 4]. |
| PubMedID- 22707881 | Status quo of chronic liver diseases, including hepatocellular carcinoma, in mongolia. |
| PubMedID- 26473344 | Nonalcoholic fatty liver disease (nafld) can lead to cirrhosis, hepatocellular carcinoma, and ultimately death. |
| PubMedID- 23418453 | Approximately 170 million people are chronically infected with hcv, and some develop progressive liver disease which may lead to cirrhosis, hepatocellular carcinoma and death [2]. |
| PubMedID- 26201636 | Purpose: metabolic syndrome (ms) is a group of recognized risk factors for the development of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 24313165 | Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma [hcc]) associated with alcoholic liver disease (ald) as well as in liver disease associated with other conditions. |
| PubMedID- 26456168 | Background: in japan, the prevalence of hepatocellular carcinoma (hcc) associated with nonviral liver disease, especially with nonalcoholic fatty liver disease (nafld-hcc) and alcoholic liver disease (ald-hcc), has been increasing. |
| PubMedID- 24801168 | As effective antifibrotic therapies are developed, these approaches could attenuate the rising surge of hepatocellular carcinoma associated with chronic liver disease. |
| PubMedID- 23140577 | Hepatitis c virus (hcv) is a hepacivirus that causes chronic liver disease, leading to hepatocellular carcinoma, cirrhosis, and chronic hepatitis in about 3% of the world population. |
| PubMedID- 26389885 | The role of this polymorphism in liver pathology is further suggested by its association with increased risk of non-alcoholic steatohepatitis [17], liver cirrhosis [18], and hepatocellular carcinoma in patients with underlying liver disease [19,20]. |
| PubMedID- 26052388 | Aim: to evaluate the association between alpha-1 antitrypsin deficiency (a1atd) and hepatocellular carcinoma (hcc) in patients with end-stage liver disease (esld). |
| PubMedID- 22675639 | Serum afp is a debated but routinely used marker for hepatocellular carcinoma (hcc) in patients with chronic liver disease [5]. |
| PubMedID- 22814828 | Objective: to examine if liver stiffness measured by magnetic resonance elastography (mre) is a risk factor for hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 26386160 | As this cohort ages, progressive hcv-related liver disease leading to cirrhosis and hepatocellular carcinoma (hcc) will place a significant burden on the healthcare system. |
| PubMedID- 22117640 | hepatocellular carcinoma develops in 2%-4% of patients with end-stage liver disease. |
| PubMedID- 23449255 | Chronic alcohol consumption is a leading cause of chronic liver disease worldwide, leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 24588677 | Purpose: to assess diagnostic performance and imaging features of gadoxetic acid-enhanced magnetic resonance (mr) imaging in small (hepatocellular carcinoma (hcc) detection in patients with chronic liver disease. |
| PubMedID- 23144154 | Interleukin-6 and oncostatin m are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker gp73. |
| PubMedID- 26202505 | Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : hcc risk assessment by vttq. |
| PubMedID- 22352098 | Patients enrolled in study were known cases of chronic liver disease and were complicated by development of hepatocellular carcinoma; those having metastasis in liver from any where were excluded. |
| PubMedID- 24282628 | Nash, but not simple steatosis, is a potentially progressive liver disease leading to cirrhosis and hepatocellular carcinoma [31]. |
| PubMedID- 26250831 | hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: us experience. |
| PubMedID- 21234351 | Vitamin a supplementation may be considered since vitamin a deficiency results in nyctalopia and dry cornea, and is associated with increased risk of hepatocellular carcinoma in patients with end-stage liver disease [117, 118]. |
| PubMedID- 26225191 | Liver resection (lr) for hepatocellular carcinoma (hcc) in patients with chronic liver disease (cld) is associated with high risks of developing significant postoperative complications and multicentric metachronous lesions, which can result in the need for repeated treatments. |
| PubMedID- 23633285 | Purpose: to determine whether the presence of a hypovascular nodule in the liver showing hypointensity on hepatocyte-phase of gadoxetic acid-enhanced magnetic resonance imaging (eob-mri) is a risk factor for hypervascular hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 20227190 | For hepatocellular carcinoma, most often without underlying liver disease in children of the western world, results of resection with partial hepatectomy remain dismal, due to a high rate of recurrence. |
| PubMedID- 26099526 | Background & aims: alcoholic steatohepatitis (ash) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. |
Page: 1 2